Qian R - Search Results

1

High expression of HOXA4 in patients with glioma indicates unfavorable clinical outcomes.

Yu Z, Liu Z, Lian X, Cheng X, Liu B, Zhang B, Wang H, Wang J, Li A, Ren Z, Pang B, Qian R, Gao Y. Yu Z, et al. Among authors: qian r. Cell Cycle. 2022 Nov;21(22):2387-2402. doi: 10.1080/15384101.2022.2096715. Epub 2022 Jul 19. Cell Cycle. 2022. PMID: 35852388 Free PMC article.

2

ELK3: A New Molecular Marker for the Diagnosis and Prognosis of Glioma.

Liu Z, Ren Z, Zhang C, Qian R, Wang H, Wang J, Zhang W, Liu B, Lian X, Wang Y, Guo Y, Gao Y. Liu Z, et al. Among authors: qian r. Front Oncol. 2021 Dec 16;11:608748. doi: 10.3389/fonc.2021.608748. eCollection 2021. Front Oncol. 2021. PMID: 34976781 Free PMC article.

3

Effects of ESCO2 or its methylation on the prognosis, clinical characteristics, immune microenvironment, and pathogenesis of low-grade glioma.

Liu Z, Cheng X, Pang B, Wang S, Liu B, Cao C, Qian R, Liang W, Zhu Y, Li P, Gao Y. Liu Z, et al. Among authors: qian r. Int Immunopharmacol. 2022 Mar;104:108399. doi: 10.1016/j.intimp.2021.108399. Epub 2022 Jan 8. Int Immunopharmacol. 2022. PMID: 35008004

4

Prognostic Significance of mRNA Expression RBBP8 or Its Methylation in Gliomas.

Liu Z, Cheng X, Lin S, Han Z, Jin H, Luan Z, Li P, Liang W, Qian R, Gao Y. Liu Z, et al. Among authors: qian r. Cell Mol Neurobiol. 2023 Jan;43(1):409-422. doi: 10.1007/s10571-022-01198-4. Epub 2022 Feb 1. Cell Mol Neurobiol. 2023. PMID: 35106666

5

Cysteine cathepsin C: a novel potential biomarker for the diagnosis and prognosis of glioma.

Cheng X, Ren Z, Liu Z, Sun X, Qian R, Cao C, Liu B, Wang J, Wang H, Guo Y, Gao Y. Cheng X, et al. Among authors: qian r. Cancer Cell Int. 2022 Feb 2;22(1):53. doi: 10.1186/s12935-021-02417-6. Cancer Cell Int. 2022. PMID: 35109832 Free PMC article.

6

Exploring the relationship between abnormally high expression of NUP205 and the clinicopathological characteristics, immune microenvironment, and prognostic value of lower-grade glioma.

Liang W, Hu C, Zhu Q, Cheng X, Gao S, Liu Z, Wang H, Li P, Gao Y, Qian R. Liang W, et al. Among authors: qian r. Front Oncol. 2023 May 22;13:1007198. doi: 10.3389/fonc.2023.1007198. eCollection 2023. Front Oncol. 2023. PMID: 37284202 Free PMC article.

7

PSRC1 Regulated by DNA Methylation Is a Novel Target for LGG Immunotherapy.

Liu Z, Liang W, Zhu Q, Cheng X, Qian R, Gao Y. Liu Z, et al. Among authors: qian r. J Mol Neurosci. 2023 Aug;73(7-8):516-528. doi: 10.1007/s12031-023-02133-y. Epub 2023 Jun 16. J Mol Neurosci. 2023. PMID: 37326762

8

ZNF480 influences the prognosis, pathogenesis, and immune microenvironment in patients with lower-grade glioma.

Zhu Q, Liu Z, Cheng X, Liang W, Wang H, Li P, Zhang J, Chen Y, Gao Y, Qian R. Zhu Q, et al. Among authors: qian r. Heliyon. 2023 Jul 17;9(7):e18185. doi: 10.1016/j.heliyon.2023.e18185. eCollection 2023 Jul. Heliyon. 2023. PMID: 37519705 Free PMC article.

9

Potential value of expression of receptor accessory protein 4 for evaluating the prognosis of lower-grade glioma patients.

Luo S, Liu Z, Chang H, Cheng X, Qian R, Gao Y, Hou C. Luo S, et al. Among authors: qian r. Aging (Albany NY). 2024 Mar 28;16(7):6188-6211. doi: 10.18632/aging.205695. Epub 2024 Mar 28. Aging (Albany NY). 2024. PMID: 38552216 Free PMC article.

10

Post-traumatic brain injury glioma: Characteristics, report of 2 cases report and literature review.

Chen K, Andrade-Barazarte H, Liang W, Zhu Q, Guo H, Li Y, Li H, Qian R. Chen K, et al. Among authors: qian r. Medicine (Baltimore). 2022 Dec 30;101(52):e32477. doi: 10.1097/MD.0000000000032477. Medicine (Baltimore). 2022. PMID: 36596004 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

712 results

Search Page

Filters